As mentioned previously, developing drugs for rare diseases has its own hurdles. According to Neil Ward, vice president of Europe, the Middle East, and Africa at PacBio, there is a lot of work to be ...

Pacific Biosciences' Q4'24 results were another disappointment, with revenue and margin misses, and 2025 guidance was notably below expectations. Underlying utilization growth (genetic data ...

Pacific Biosciences of California has a 12-month low of $1.16 and a 12-month high of $6.09. The company has a quick ratio of 8.64, a current ratio of 9.74 and a debt-to-equity ratio of 1.97.

Surging tropical activity in the South Pacific Ocean produced a relatively rare occurrence Tuesday: three named tropical cyclones active at the same time: Alfred, Rae and Seru. It’s the first ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Copyright 2025 The Associated Press. All Rights Reserved. In this photo released by Agence Kampuchea Press (AKP), Cambodian Prime Minister Hun Manet, right, shakes ...

South Africa’s antitrust watchdog penalized technology companies including Alphabet Inc.’s Google and Meta Platforms Inc.’s Facebook for anti-competitive practices it said hurt local media ...

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies, including gene ...

Tokyo | China has secured a strategic foothold in the Pacific’s mineral resources, signing a five-year seabed exploration agreement with the Cook Islands amid escalating regional tensions over ...